AHMEDABAD, India, March 21, 2013 /PRNewswire/ --
Lambda Therapeutic Research successfully conducted a symposium on "Innovation in Clinical Trials"; on the 15th and 16th of March, 2013 at Ahmedabad. Around 50 delegates from different pharmaceutical & Biotechnology organisations across India participated in this two-day symposium, which was inaugurated by Dr. H.G. Koshiya - Commissioner, Food & Drug Control Administration, Government of Gujarat and Dr. Ramkishan (ADC) - CDSCO, Zonal Office, Ahmedabad. Lambda's initiative to organise such a knowledge sharing event in Ahmedabad and committed efforts of their Managing Director, Mrs. Bindi Chudgar as well as Team Lambda were acknowledged and appreciated by all delegates.
Renowned and eminent scientists from the Drug Development & Clinical Research arena assembled to discuss and explore new thoughts and learning to understand the ever changing dynamics of the industry. The Current Regulatory Environment and the new regulations were discussed with the Commissioner, Food & Drug Control Administration - Gujarat and Assistant Drug Controller, CDSCO, Zonal Office - Ahmedabad, who also attended the symposium. Mr. Sanjeev Kaul (MD, Chrys Capital Advisors) and Mr. Sudarshan Jain (MD, Abbott Healthcare) were among the eminent speakers invited for the symposium.
Topics like the latest challenges in Global Clinical Trials, Market Outlook for the Indian Clinical Trial Industry, Investment trends in Drug Discovery and Development, Current trends in Data Management in Clinical Trials, etc. and other topics straddling all the latest trends and updates in the industry were well received. The objective of conducting this symposium was met and knowledge in the arenas of innovation in drug development and clinical research was shared in the group.
All the participants felt the need of conducting such symposiums in future and Lambda is determined to continue with this precedent established by holding such events on a more regular basis in the future.
About Lambda Therapeutic Research Limited
Lambda Therapeutic Research Limited is a leading global Clinical Research Organization (CRO) headquartered in Ahmedabad, India, with facilities and operations in Mumbai (India), Toronto (Canada), Warsaw (Poland) and London (UK).
Lambda offers full spectrum clinical trial solutions empowered by more than 14 years of service to the biopharmaceutical and generic industry. At Lambda, our comprehensive services are executed with committed efforts, to deliver positive results. Led by a management team of highly qualified & experienced industry leaders, we apply innovative technologies, therapeutic expertise and a commitment to quality in order to help clients develop products safely, effectively and quickly.
For more information, visit www.lambda-cro.com.
Primary Media Contact: Pritesh Trivedi, email@example.com, 91-97272-60309
Secondary Media Contact: Gaurang Darji, firstname.lastname@example.org, 91-99250-38960
SOURCE Lambda Therapeutic Research Limited